Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

AmgenAMGN

Amgen 8-K

Filing date ·

The company said total revenues for Q3 2026 rose 8% from Q3 2025 to $10.4 billion. It said product sales grew 8%, driven by volume growth.

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.